{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T21:07:59Z","timestamp":1719263279051},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.leukres.2011.04.020","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T09:54:02Z","timestamp":1305885242000},"page":"1355-1359","source":"Crossref","is-referenced-by-count":4,"title":["AID expression is correlated with Bcr-Abl expression in CML-LBC and can be down-regulated by As2O3 and\/or imatinib"],"prefix":"10.1016","volume":"35","author":[{"given":"ZiJie","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YuMing","family":"wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JinXing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoBo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YuXia","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.leukres.2011.04.020_bib0005","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.07.030","article-title":"The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia","volume":"16","author":"Klemm","year":"2009","journal-title":"Cancer Cell"},{"issue":"14","key":"10.1016\/j.leukres.2011.04.020_bib0010","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2011.04.020_bib0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/asheducation-2007.1.384","article-title":"The biology of CML blast crisis","author":"Radich","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.leukres.2011.04.020_bib0020","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601485","article-title":"Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation","volume":"26","author":"Coluccia","year":"2007","journal-title":"EMBO J"},{"issue":"11","key":"10.1016\/j.leukres.2011.04.020_bib0025","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis","volume":"103","author":"Calabretta","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2011.04.020_bib0030","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1084\/jem.20070884","article-title":"A role for AID in chromosome translocations between c-myc and the IgH variable region","volume":"204","author":"Dorsett","year":"2007","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.leukres.2011.04.020_bib0035","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.molimm.2006.03.015","article-title":"Activation-induced cytidine deaminase acts on double-strand breaks in vitro","volume":"44","author":"Shen","year":"2007","journal-title":"Mol Immunol"},{"issue":"19","key":"10.1016\/j.leukres.2011.04.020_bib0040","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1073\/pnas.0402009101","article-title":"Genome-wide somatic hypermutation","volume":"101","author":"Wang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.leukres.2011.04.020_bib0045","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/carcin\/bgm201","article-title":"Oncogenic events triggered by AID, the adverse effect of antibody diversification","volume":"28","author":"Perez-Duran","year":"2007","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.leukres.2011.04.020_bib0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.biocel.2008.01.018","article-title":"AID expression and human cancer development","volume":"40","author":"Marusawa","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.leukres.2011.04.020_bib0055","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1084\/jem.20062662","article-title":"Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells","volume":"204","author":"Feldhahn","year":"2007","journal-title":"J Exp Med"},{"issue":"38","key":"10.1016\/j.leukres.2011.04.020_bib0060","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1038\/sj.onc.1210344","article-title":"Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling","volume":"26","author":"Endo","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.leukres.2011.04.020_bib0065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm1566","article-title":"Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium","volume":"13","author":"Matsumoto","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.leukres.2011.04.020_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-005-1743-4","article-title":"Host factors are important in determining clinical outcomes of Helicobacter pylori infection","volume":"41","author":"Chiba","year":"2006","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.leukres.2011.04.020_bib0075","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.cell.2009.11.030","article-title":"Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer","volume":"139","author":"Lin","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2011.04.020_bib0080","doi-asserted-by":"crossref","unstructured":"Gruber TA, Chang MS, Sposto R, M\u00fcschen M. Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia. Cancer Res. 70(19):7411\u201320.","DOI":"10.1158\/0008-5472.CAN-10-1438"},{"key":"10.1016\/j.leukres.2011.04.020_bib0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/asheducation-2008.1.427","article-title":"Novel agents in CML therapy: tyrosine kinase inhibitors and beyond","author":"Melo","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7198","key":"10.1016\/j.leukres.2011.04.020_bib0090","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","article-title":"PML targeting eradicates quiescent leukaemia-initiating cells","volume":"453","author":"Ito","year":"2008","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.leukres.2011.04.020_bib0095","first-page":"3409","article-title":"BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity","volume":"60","author":"Puccetti","year":"2000","journal-title":"Cancer Res"},{"issue":"July (7)","key":"10.1016\/j.leukres.2011.04.020_bib0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0301-472X(02)00836-6","article-title":"In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia","volume":"30","author":"La Ros\u00e9e","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2011.04.020_bib0105","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1084\/jem.20101321","article-title":"Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90","volume":"207","author":"Orthwein","year":"2010","journal-title":"J Exp Med"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611002098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611002098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T20:50:55Z","timestamp":1560199855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611002098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0145212611002098"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.04.020","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}